NCT00000334View on ClinicalTrials.gov

Comparison of Buprenorphine and Methadone - 3

PHASE2CompletedINTERVENTIONAL
0
Timeline

Start Date

December 1, 2002

Primary Completion Date

November 1, 2004

Study Completion Date

January 15, 2005

Conditions
Opioid-Related Disorders
Interventions
DRUG

Buprenorphine

Trial Locations (1)

20422

Washington DC VA, Washington D.C.

All Listed Sponsors
collaborator

Washington D.C. Veterans Affairs Medical Center

FED

lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00000334 - Comparison of Buprenorphine and Methadone - 3 | Biotech Hunter | Biotech Hunter